NR4A nuclear receptors in immunity and atherosclerosis

Curr Opin Lipidol. 2013 Oct;24(5):381-5. doi: 10.1097/MOL.0b013e3283643eac.

Abstract

Purpose of review: To understand chronic inflammatory diseases such as atherosclerosis, we require in-depth knowledge on immune-cell differentiation, function of specific immune-cell subsets and endothelial cell-mediated extravasation. In this review, we summarize a number of very recent observations on the pivotal function of NR4A nuclear receptors in immunity and atherosclerosis.

Recent findings: NR4A nuclear receptors are involved in negative selection of thymocytes, Treg differentiation and the development of Ly6C monocytes. Nur77 and Nurr1 attenuate atherosclerosis in mice whereas NOR-1 aggravates vascular lesion formation.

Summary: These exciting, novel insights on the function of NR4A nuclear receptors in immunity, vascular cells and atherosclerosis will initiate a plethora of studies to understand the underlying molecular mechanisms, which will culminate in the identification of novel NR4A targets to modulate chronic inflammatory disease.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Atherosclerosis / immunology*
  • Atherosclerosis / pathology
  • Cell Differentiation / immunology
  • Endothelial Cells / immunology*
  • Endothelial Cells / pathology
  • Humans
  • Mice
  • Monocytes / immunology*
  • Monocytes / pathology
  • Nuclear Receptor Subfamily 4, Group A, Member 1 / immunology*
  • Nuclear Receptor Subfamily 4, Group A, Member 2 / immunology*
  • T-Lymphocytes, Regulatory / immunology*
  • T-Lymphocytes, Regulatory / pathology

Substances

  • NR4A1 protein, human
  • NR4A2 protein, human
  • Nr4a1 protein, mouse
  • Nr4a2 protein, mouse
  • Nuclear Receptor Subfamily 4, Group A, Member 1
  • Nuclear Receptor Subfamily 4, Group A, Member 2